Company Filing History:
Years Active: 2025
Title: Sophie Decollogny: Innovator in Pharmaceutical Dosage Forms
Introduction
Sophie Decollogny is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms that incorporate antibodies. Her innovative approach has the potential to enhance the effectiveness of treatments administered in the gastrointestinal tract.
Latest Patents
Sophie holds a patent for a method titled "Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization." This invention focuses on creating immediate and sustained release solid dosage forms that include antibodies and their functional fragments. The method involves wet granulation, extrusion, and spheronization, with an option for a delayed release coating. The solid dosage forms produced by this method are designed for topical treatment in the gastrointestinal tract of patients.
Career Highlights
Sophie Decollogny is currently employed at Tillotts Pharma AG, where she continues to advance her research and development efforts. Her work is instrumental in improving pharmaceutical formulations, particularly those that require precise delivery mechanisms.
Collaborations
Throughout her career, Sophie has collaborated with esteemed colleagues, including Felipe Varum and Roberto Bravo. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in pharmaceutical sciences.
Conclusion
Sophie Decollogny's contributions to the field of pharmaceuticals, particularly through her patented methods for solid dosage forms, highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has the potential to improve patient care through innovative drug delivery systems.